Tranexamic acid: Difference between revisions
Ostermayer (talk | contribs) |
Ostermayer (talk | contribs) |
||
Line 35: | Line 35: | ||
==External Links== | ==External Links== | ||
*[http://www.emcurious.com/blog-1/2014/7/11/bcej55h3s3rk93uekwtvw9biixn0y8 EMCurious - TXA Trauma Lit Review] | *[http://www.emcurious.com/blog-1/2014/7/11/bcej55h3s3rk93uekwtvw9biixn0y8 EMCurious - TXA Trauma Lit Review] | ||
*[http://www.emdocs.net/txa-use-trauma-update/ EMDocs TXA] | |||
==Source== | ==Source== |
Revision as of 14:26, 10 December 2014
Background
- Action: Antifibrinolytic agent
- Availability:
- Ampule of 1 Gm in 10 mL
Indication
Severely bleeding trauma patient, systolic blood pressure of <90 and/or heart rate > 110 beats/min., with expected requirement for massive transfusion.
Contraindication/Exclusion Criteria
- Greater than 3 hours from injury
- Known sensitivity to TXA
- Previous DVT or Pulmonary Embolism
Administration
- Adult dose- Total of 2 Gms
- Initial bolus of 1 Gm over 10 minutes (Slow IV push). Draw up with filter needle.
- Maintenance: additional 1 Gm over next 8 hours (mix in 50 mL of NS). Call Pharmacy to mix and deliver the continuous infusion.
- Pediatric dose- (weight based)
- Initial bolus of 20 mg/kg IV Bolus over 10 minutes
- Maintenance: 10 mL/kg/hr over next 8 hours
No additional laboratory tests required.
Adverse Reactions
- Thrombotic events
- Hypotension with rapid injection
- Nausea, vomiting, diarrhea
- Impaired color vision and other visual disturbances
See Also
External Links
Source
Harbor-UCLA Tranexamic Acid (TXA) Guidelines for Administration in Trauma